Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;95(4):597-603.
doi: 10.3324/haematol.2009.012864.

Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma

Christopher J Stasik  1 , Hiroaki Nitta, Wenjun Zhang, Charles H Mosher, James R Cook, Raymond R Tubbs, Joseph M Unger, Tracy A Brooks, Daniel O Persky, Sarah T Wilkinson, Thomas M Grogan, Lisa M Rimsza
Affiliations

Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma

Christopher J Stasik et al. Haematologica. 2010 Apr.

Abstract

Background: Translocations involving the MYC gene and increased MYC mRNA levels are associated with poor outcome in diffuse large B-cell lymphoma. However, the presence of increased MYC gene copy number and/or polysomy of chromosome 8 have not been previously described.

Design and methods: Utilizing dual color chromogenic in situ hybridization, we investigated MYC gene copy and chromosome 8 centromere numbers in 52 cases of diffuse large B-cell lymphoma. Cases were divided into those with "increased" or "not increased" MYC gene copy number for comparison with MYC mRNA levels, Ki-67 values, and survival.

Results: Increased MYC gene copy number was present in 38% of cases. Overall, the average MYC mRNA level was 2398 (range, 342 - 9783) and the percentage of nuclei positive for Ki-67 was 57.5% (range, 20-87%). Within the group with increased MYC copy number, the MYC mRNA values ranged from 816 to 5912 (average, 2843) and the Ki-67 values ranged from 23% to 83% (average, 57%). Within the group with not increased MYC copy number, MYC mRNA values ranged from 342 to 9783 (average, 2118) and the Ki-67 values ranged from 20% to 87% (average, 58%). There was a statistically significant relationship between increased MYC gene copy number and increased MYC mRNA (P=0.034) and a trend toward a relationship between increased mRNA and higher Ki-67 values.

Conclusions: This is the first report that low level copy number increases are common in diffuse large B-cell lymphoma and that these changes correlate with MYC mRNA in a statistically significant manner. MYC copy number changes are an additional possible molecular mechanism that may result in increased mRNA and, likely, high proliferation and poor outcome.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The MYC probe location on chromosome 8q24.
Figure 2
Figure 2
(A) Normal tonsil control with two copies each of MYC (blue) and chromosome 8 centromere (red) per cell (dual color CISH, Nikon Eclipse 80i, x400) Occasional cells have less than two copies due to sectioning of the tissue. (B) Diffuse large B-cell lymphoma with increased MYC gene copy number (blue) relative to chromosome 8 centromere (red) per cell (dual color CISH, Nikon Eclipse 80i, x400). In most cells, clearly separate MYC probes can be discerned.
Figure 3.
Figure 3.
Cases were divided into those with increased MYC copy number and not increased MYC copy number by CISH and average MYC mRNA by qNPA was compared between the two groups. The open circle represents the case with a non-IG associated translocation.
See this image and copyright information in PMC

References

    1. Stein H, Warnke RA, Chan WC, Jaffe ES, Chan JKC, Gatter KC, et al. Diffuse large B-cell lymphoma, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer; 2008. pp. 233–7.
    1. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(25):1937–47. - PubMed
    1. Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med. 2004;350(18):1828–37. - PubMed
    1. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002;8(1):68–74. - PubMed
    1. Tome ME, Johnson DBF, Rimsza LM, Roberts RA, Grogan TM, Miller TP, et al. A redox signature score identifies diffuse large B-cell lymphorna patients with a poor prognosis. Blood. 2005;106(10):3594–601. - PMC - PubMed

Publication types

MeSH terms